Is cannabis safe after 65? Stanford experts reveal 5 risks older adults should know
Cannabis use among older adults is rising fast, but today’s marijuana is far more potent than many people realize — and experts warn the risks may be underestimated. Stanford Medicine specialists say modern cannabis can increase the chances of heart problems, falls, memory issues, dangerous drug interactions, and even addiction, especially for people over 65.
External link. We are not responsible for the content.
Read more ↗More From ScienceDaily Psychedelics
New psychedelic-like drugs could treat depression without making you trip
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. ...
Scientists say 7 days of meditation can rewire your brain
A single week of intensive meditation and mind-body practices led to measurable changes across the brain and body. Re...
A new “magic mushroom” drug could treat depression without psychedelic hallucinations
Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending s...
Latest News
The Rush for Iboga Looks Different from Gabon
Gabonese civil servant and environmental lawyer Georges Gassita on what the ibogaine rush looks like from inside Gabo...
The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet
The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psy...
Do people hear voices when they take ayahuasca? 5 Questions with social anthropologist David Dupuis
Dupuis discusses how auditory hallucinations during psychedelic trips have been overlooked.
One of Psychedelia’s Most Notorious Gurus Is Officially Put on Blast
PLUS, stories about datura, the Huni Kuin, and Oregon's drug policy programs. [...] Read More... The post One of Psyc...
LSD Just Joined The Establishment
This Week’s Sunday Insider: The most anti-establishment Psychedelic in history is becoming part of the establishment.
Big changes ahead for Oregon’s psilocybin agency, New bill seeks to turn Trump’s psychedelics executive order into permanent law
Plus: Compass Pathways announces new Phase 3 results, and Lawsuit against LSD company Definium is dismissed